Greg Cima

In a partnership with OpenAI, Color Health has developed its Copilot software to create screening plans as well as pretreatment workups for cancer patients.

The cancer testing firm said it has been partnering with pharma companies on clinical trials and test development and aims to soon develop its patient testing business.

The firm is expanding its lab capabilities and leveraging its test development reputation to form partnerships early in the drug development process.

In a bid to expand recognition and treatment of alpha-1 antitrypsin deficiency, a cause of COPD, Grifols is making its over-the-counter genetic test available for free.

AI firm Owkin used distributed on-site analysis of whole-slide images to identify triple-negative breast cancer patients who might respond to neoadjuvant therapy.

State labs and commercial companies see rising spinal muscular atrophy test volumes as screening programs launch in US states and European countries, among others.

The firm is working on more assays to help decide which cancer patients are suitable for immunotherapies and hopes to establish a US-based lab in 2023.

The CDPath prognostic tool gives Crohn's patients risk scores for serious complications within three years, so they can make more informed treatment decisions.